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The central nervous system of persons with Down syndrome presents cytoarchitectural abnormalities that
likely result from gene-dosage effects affecting the expression of key developmental genes. To test this
hypothesis, we have investigated the transcriptome of the cerebellum of the Ts1Cje mouse model of Down
syndrome during postnatal development using microarrays and quantitative PCR (qPCR). Genes present
in three copies were consistently overexpressed, with a mean ratio relative to euploid of 1.52 as determined
by qPCR. Out of 63 three-copy genes tested, only five, nine and seven genes had ratios >2 or <1.2 at postnatal
days 0 (P0), P15 and P30, respectively. This gene-dosage effect was associated with a dysregulation of the
expression of some two-copy genes. Out of 8258 genes examined, the Ts1Cje/euploid ratios differed signifi-
cantly from 1.0 for 406 (80 and 154 with ratios above 1.5 and below 0.7, respectively), 333 (11 above 1.5 and 55
below 0.7) and 246 genes (59 above 1.5 and 69 below 0.7) at P0, P15 and P30, respectively. Among the two-
copy genes differentially expressed in the trisomic cerebellum, six homeobox genes, two belonging to the
Notch pathway, were severely repressed. Overall, at P0, transcripts involved in cell differentiation and deve-
lopment were over-represented among the dysregulated genes, suggesting that cell differentiation and
migration might be more altered than cell proliferation. Finally, global gene profiling revealed that transcrip-
tion in Ts1Cje mice is more affected by the developmental changes than by the trisomic state, and that there
is no apparent detectable delay in the postnatal development of the cerebellum of Ts1Cje mice.
INTRODUCTION
Down syndrome results from trisomy of human chromosome
21 and is the most frequent genetic cause of mental retardation,
occurring in1 in 800 newborns. Most cases are full trisomies,
and about 300 genes are triplicated (1). This dosage imbalance
causes dysfunction of developmental and physiological pro-
cesses, but there is a puzzling variability among affected indi-
viduals in terms of the number of clinical features observed and
their severity (2). Therefore, one of the most relevant questions
in Down syndrome research concerns the identification of the
genes (within or outside of chromosome 21) that contribute
both to the phenotype and to the phenotypic variability. In
addition, we believe that the identification of these genes is
essential for the development of new therapeutic approaches.
The search for gene targets that may be amenable to thera-
peutic approaches has accelerated in the past few years with
the publication of the human genome sequence and the use
of large-scale gene expression studies such as SAGE and
microarrays (3–7).
Because of the prominence of mental retardation, brain has
been the subject of particular interest in research on Down
syndrome, but a systematic study of gene expression in
brain during development, particularly at postnatal stages, is
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only possible in animal models. Mouse models for Down
syndrome are trisomic for single gene, for several genes or
for a large segment corresponding to the distal part of chromo-
some 16, orthologous to a large portion of human chromosome
21 (8). Two models of segmental trisomy 16 have been gene-
rated, the Ts65Dn mice and the Ts1Cje mice (9–11). These
models have revealed previously unknown phenotypes that
may be relevant to Down syndrome, such as a substantial
loss of glutamatergic granule cells in the internal layer of
the cerebellum in adult (12,13).
We studied the transcriptome during postnatal development
of the cerebellum for two reasons. First, there are massive
developmental changes during the first 20 days after birth.
During this period, granule cells, which represent 40% of
the total number of neurons of the mature cerebellum, prolifer-
ate, migrate and differentiate from the external to the internal
layer, and Purkinje cells develop their dense dendritic trees
making connections with other cells. Secondly, gene profiling
during postnatal development of the cerebellum in mice is
well documented (14,15), Furthermore, previously investi-
gated mutants of the cerebellum could serve as a reference
to our study (14).
The Ts1Cje Down syndrome model was used in the present
study after backcrossing the mice onto a pure genetic back-
ground to reduce variability in gene expression. Ts1Cje mice
carry a segmental duplication of the syntenic region ortho-
logous to human chromosome 21 from Sod1 to Znf295, includ-
ing about 95 genes (8,10,11). Differential gene expression was
studied at postnatal days 0 (P0), P15 and P30 in the cerebellum
using Affymetrix U74Av2 microarrays. Expression of genes
was also measured in parallel by quantitative PCR (qPCR).
Two groups of genes have been characterized: one that con-
tains the triplicated genes and shows a consistent gene-dosage
effect (approximately 1.5 overexpression ratio in Ts1Cje mice
when compared with euploid mice) during postnatal develop-
ment, and the second that contains euploid genes that are sig-
nificantly differentially expressed (over or under) and are
mainly involved in cell differentiation and development.
RESULTS
Experimental data and analysis: validation
Using Affymetrix murine genome U74Av2 microarrays, we
measured the expression levels of 12 488 genes (half known
genes and half ESTs) in the cerebellum of Ts1Cje and
euploid mice each at P0, P15 and P30 during postnatal devel-
opment. The mean expression value for each gene was calcu-
lated from duplicate experiments performed on the six groups
of three animals each. According to the Affymetrix algorithm,
8287 genes were found to be expressed at least at one time
point (see Materials and Methods for details on the filtering
step and Supplementary Material, Table S1 for a complete
list of the 8287 genes). Two statistical analyses were
applied to the data: variability analysis of microarray data
(VARAN), a freely available web server performing a signal
intensity-based analysis of the log 2 expression ratios variabil-
ity deduced from DNA microarray raw data (16), and
ANOVA. The parametrization chosen for the ANOVA
allowed the selection of genes either involved in normal
postnatal development of the cerebellum or differentially
expressed in Ts1Cje mice when compared with euploid mice
at one particular stage of development (ai and bi parameters,
respectively, in Table 1).
To validate our experimental data and analysis, we com-
pared genes differentially expressed between P0 and P15 or
between P15 and P30 (ai parameters) in either euploid mice
or Ts1Cje mice with genes differentially expressed along
normal postnatal development of the cerebellum as reported
by Diaz et al. (14). Their experimental data, which were
obtained on the mouse RIKEN 19-K microarray, were ana-
lyzed using ANOVA with the parametrization described in
Table 1 (ai parameters). Many genes differentially expressed
during postnatal development of the cerebellum, such as
GABA-a6 and GABA-d, myelin oligodendrocyte glyco-
protein and parvalbumin (Supplemental Material, Table S2),
belonged to the cell differentiation class B of Diaz et al.
(14). Discordance between the two studies is, generally, the
result of differences in the gene content of the two micro-
arrays. We thus concluded that our data were as informative
as those of Diaz et al. (14).
Gene expression in the Ts1Cje cerebellum: triplicated
versus euploid genes from mouse chromosome 16
Of the 8287 expressed genes, 145 were from mouse chromo-
some 16, and among them 29 were triplicated in Ts1Cje mice.
At P0, P15 and P30, mean expression ratios of triplicated
genes between Ts1Cje and controls were 1.66, 1.32 and 1.32
at P0, P15 and P30, respectively, whereas with euploid
genes the ratios were 1.08, 1.12 and 1.02 at P0, P15 and
P30, respectively (Fig. 1). After ANOVA, 12, six and nine tri-
plicated genes were found to be statistically overexpressed
(a ¼ 1%) in Ts1Cje mice when compared with euploid mice
at P0, P15 and P30, respectively (Table 2). Among these
genes, four (Dscr3, HMGP14, Donson, C21orf4 ) were over-
expressed at all three time points.
qPCR on 78 genes from chromosome 16 (15 euploid and 63
triplicated) showed overexpression of the triplicated genes
with mean ratios of 1.56, 1.43 and 1.55 at P0, P15 and P30,
respectively, whereas the euploid genes from chromosome
16 had ratios very close to 1.0 (1.04, 1.00 and 1.01 at P0,
P15 and P30, respectively) (Fig. 2; Supplementary Material,
Table S3). The 18 control genes mapping to chromosomes
other than 16 and described previously (17) showed ratios of
1.02, 1.08 and 1.03 at P0, P15 and P30, respectively. Gene
expression of the 33 euploid genes from chromosome 16
and other chromosomes did not reveal any significant corre-
lations between stages. Interestingly, for the triplicated
genes, there was a highly significant correlation (P , 0.01)
between the P15 and P30 time points. Only a few genes had
ratios above 2 (three, two and five genes at P0, P15 and
Table 1. Parameters of gene expression levels
P0 P15 P30
Euploid m mþ a2 mþ a3
Ts1Cje mþ b1 mþ a2þ b2 mþ a3þ b3
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Figure 1. Distribution of gene expression ratios between Ts1Cje and euploid mice in the cerebellum at postnatal days 0 (P0), P15 and P30 using mouse genome
U74Av2 Affymetrix microarray data. Genes are subdivided as euploid genes from or outside mouse chromosome 16 (MMU16) and trisomic genes from
MMU16.
Table 2. List of triplicated genes found to be differentially expressed by ANOVA of microarray data
Gene (probe set) Stage Ts/Eu ratio U74Av2 Fisher VARAN selected Ts/Eu ratio qPCR
Atp5o (99128_at) P15 1.70 29.4 Yes 1.42
Atp5o (99128_at) P30 1.45 15.1 1.39
C21orf4 (96340_at) P0 1.48 69.5 1.88
C21orf4 (96340_at) P15 1.62 110.8 1.45
C21orf4 (96340_at) P30 1.41 57.6 1.52
Donson (94386_at) P0 1.91 97.1 1.66
Donson (94386_at) P15 1.45 30.5 1.38
Donson (94386_at) P30 1.78 76.1 Yes 1.38
Dscr1 (100555_at) P0 1.48 29.4 1.62
Dscr1 (100555_at) P15 1.74 63.3 1.49
Dscr3 (101104_at) P0 1.32 14.3 1.39
Dscr3 (101104_at) P15 1.58 40.6 1.45
Dscr3 (101104_at) P30 1.48 29.5 1.39
Dscr3 (162486 f_at) P0 1.70 18.4 1.39
Ets2 (94246_at) P0 1.23 14.5 1.45
Ets2 (94246_at) P30 1.29 21.4 1.78
Gart (100066_at) P0 1.45 34.9 1.43
Gart (100066_at) P30 1.55 51.7 1.53
GCR-DNABF (92233_at) P0 1.55 38.6
GCR-DNABF (92233_at) P30 1.70 58.3 Yes
Hmgp14 (96699_at) P0 1.58 87.9 Yes 1.84
Hmgp14 (96699_at) P15 1.35 35.4 1.19
Hmgp14 (96699_at) P30 1.29 28 1.33
Ifnar1 (100483_at) P30 2.04 28 Yes 1.64
Il10rb (99491_at) P0 1.32 15.2 1.42
Myo5a (160899_at) P0 1.51 17.7 1.84
Comparison with VARAN (‘yes’ indicates that the gene was selected with VARAN) (16) and qPCR (mean values of ratios are indicated). Ts, trisomic;
Eu, euploid.
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P30, respectively) or below 1.2 (two, seven and five genes at
P0, P15 and P30, respectively).
qPCR and microarray measurements were highly correlated
(P , 0.01) for 45 transcripts tested that were present in both
microarray and qPCR studies. A single and expected excep-
tion was the Sod1 transcript. The wild-type Sod1 gene is com-
posed of five exons, but in Ts1Cje mice a neomycin cassette is
inserted into exon 3, thereby generating a shorter transcript
with only exons 1, 2 and 5 (18). DNA probes on microarrays
detected this new transcript, but qPCR did not, because the
primers span exons 3 and 4 (17).
Gene expression in the Ts1Cje cerebellum: euploid
genes from all chromosomes (statistical analysis and
validation by qPCR)
In addition to the triplicated genes from chromosome 16 that
were found to be consistently overexpressed in Ts1Cje mice
when compared with euploid mice, euploid genes from
chromosomes other than 16 were also found to be differen-
tially expressed at P0, P15 and P30. A first statistical analysis
of the data using VARAN selected a total of 95 genes with
ratios between Ts1Cje and euploid ranging from 0.1 to 0.8
and from 1.2 to 70.7, respectively. Five genes were from the
triplicated segment of chromosome 16, and 90 were euploid
genes. Table 3 displays the number of genes differentially
expressed deduced from the four independent analysis at
each time point (see Data Analysis in Materials and
Methods). Overlaps between the four analyses gave the final
number of differentially expressed genes: 13, 57 and 25 at
P0, P15 and P30, respectively (Table 3). These genes are
listed in Table 4. No differentially expressed genes were in
common for all three developmental stages studied.
However, three genes were in common between P0 and P15
and three other genes between P15 and P30 (bold in Table 4).
A second statistical analysis, ANOVA, was applied to the
data. Table 5 gives the number of genes that are differen-
tially expressed (over or under) and the test of the nullity of
each parameter for several values of the risk of type I error
(1, 0.1 and 0.01%). For a 1% risk, the number of genes
differentially expressed is much higher between the stages of
development (24.6 and 27.5% between P0 and P15 and
between P15 and P30, respectively) than between the trisomic
versus euploid state (5.1, 4.1 and 3.1% at P0, P15 and P30,
respectively). A complete list of genes is included in
Supplementary Material, Table S4. All genes differentially
expressed from VARAN were also detected by ANOVA and
corresponded to the short list in Table 4, indicating that
analysis with VARAN is more stringent than with ANOVA.
At P0, 86 and 154 genes had ratios above 1.5 and below
0.7, respectively. At P15, more genes had ratios below 0.7
than above 1.5 (154 and 86 genes, respectively). At P30, 63
and 69 genes had ratios above 1.5 and below 0.7, respectively.
Thirty-one genes were in common between all three stages
(Supplementary Material, Table S4). Figure 3 represents
gene expression ratios between Ts1Cje and euploid mice
with respect to the value of their statistic (Fisher), and
shows that variations are more significant (higher Fisher) at
P0 and P15 than at P30. Differentially expressed genes are
either up- or down-regulated, and nearly all triplicated genes
belong to the up-regulated genes.
Classification of the differentially expressed genes from
ANOVA according to gene ontology showed a significant
enrichment only at P0 for GO categories GO : 0007275
(P ¼ 0.00079) and GO : 0030154 (P ¼ 0.00051), correspond-
ing to genes involved in cell development and differentiation,
respectively. Among the 419 differentially expressed genes
at P0 (Table 5, Ts1Cje/euploid at P0 with a ¼ 1%), there
were 297 genes with annotated ontology of which six and
17 were involved in cell differentiation and development,
respectively.
Figure 2. Differences in the expression of 78 genes frommouse chromosome 16 (MMU16) and 18 control genes outsideMMU16 between Ts1Cje and euploidmice
in the cerebellum at P0, P15 and P30 by real-time qPCR. Genes are ordered according to their chromosomal location (MMU16 or non-MMU16, for the MMU16
genes the order along the chromosome is respected) and their copy number (euploid or trisomic). Mean expression ratios (n ¼ 5) are indicated at the bottom.
Table 3. Number of differentially expressed genes among the 8287 genes
detected on U774Av2 Affymetrix microarray according to VARAN (1%
threshold)
P0 P15 P30
Euploid1/Ts1Cje1 100 166 203
Euploid1/Ts1Cje2 179 377 283
Euploid2/Ts1Cje1 330 225 261
Euploid2/Ts1Cje2 259 248 233
Differentially expressed genes (%) 13 (0.16) 57 (0.69) 25 (0.30)
The short list (95 genes) is given in Table 4. Numbers in superscript
indicate replicate experiments on pools of cerebellum.
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Table 4. List of genes whose expression is changed in Ts1Cje mice when compared with euploids according to both VARAN and ANOVA
Gene Probe set Stage Ts/Eu ratio U74Av2 Fisher
Adenosine deaminase 98632_at P15 3.31 1.9
Adenylate cyclase 6 102321_at P15 1.95 69.4
Aminolevulinic acid synthase 2, erythroid 92768_s_at P15 0.30 50.7
Astrotactin 1 92702_at P15 0.23 14.9
ATP synthase, Hþ transporting, mitochondrial F1 complex,
O-subunit
99128_at P15 1.70 29.4
ATPase, Naþ/Kþ transporting, alpha 1 polypeptide 93797_g_at P0 0.44 63.4
Carbonic anhydrase 2 92642_at P30 0.63 42.5
Cathepsin C 101019_at P15 4.47 75.3
CD151 antigen 97932_f_at P15 2.00 28.9
Chromogranin B 92841_f_at P15 0.71 28.8
Copine 6 93151_at P15 6.61 51.3
Cytoplasmic polyadenylation element binding protein 160680_at P15 1.55 0.6
Distal-less homeobox 1 98394_at P15 70.79 181.8
DNA segment, Chr 6, ERATO
doi 109, expressed
96754_s_at P15 1.86 62.8
ELKL motif kinase 99458_i_at P30 1.70 64.1
Eomesodermin homolog (Xenopus laevis ) 93880_at P30 2.45 10.5
EST 99849_at P0 1.58 33.9
EST 96731_at P15 2.09 111.2
EST 94106_at P15 1.91 311.3
EST 96755_at P15 1.91 9
EST 161050_at P15 1.58 29.5
EST 98594_at P15 0.59 12.4
EST 96215_f_at P15 0.49 29.1
EST 104477_at P15 0.21 79
EST 103432_at P15 0.11 19.8
EST 98525_f_at P30 1.78 95
EST 103211_at P30 0.48 5.2
Expressed sequence AA408420 96541_at P15 1.86 70.2
Expressed sequence AI467657 92202_g_at P30 5.13 157.8
Expressed sequence AI551766 104235_at P15 2.19 43.4
Expressed sequence AI852661 95397_at P15 1.86 20.1
Expressed sequence C80126 103295_at P30 0.54 47.7
Expressed sequence C87222 101929_at P15 1.41 100.4
Fatty acid binding protein 7, brain 98967_at P30 0.46 52.8
FK506 binding protein 12-rapamycin associated
protein 1
104708_at P30 2.14 20.6
FK506 binding protein 5 (51 kDa) 94297_at P30 2.69 58.7
Glutamate receptor, ionotropic, NMDA2C (epsilon 3) 97726_at P15 0.56 1.9
Glutamine synthetase 94852_at P0 0.45 365.3
Glutamine synthetase 94852_at P15 2.69 552.4
Hemoglobin alpha, adult chain 1 94781_at P15 0.39 217.2
Hemoglobin alpha, adult chain 1 94781_at P30 0.63 50.7
Hemoglobin, beta adult major chain 101869_s_at P15 0.49 686.9
Hemoglobin, beta adult major chain 162457_f_at P15 0.32 65.9
Hemoglobin, beta adult minor chain 103534_at P15 0.38 93
Hemoglobin, beta adult minor chain 103534_at P30 0.38 90.5
High mobility group nucleosomal binding
domain 1
96699_at P0 1.58 87.9
Homeo box A5 103086_at P0 0.13 396.2
Homeo box B5 103666_at P0 0.17 45
Homeo box D4 102380_s_at P0 0.18 21.6
Hydroxysteroid 17-beta dehydrogenase 11 102370_at P15 1.78 81
Immunoglobulin superfamily, member 4 93604_f_at P30 1.66 119.2
Inactive X-specific transcripts 99126_at P15 38.90 57.4
Interferon (alpha and beta) receptor 100483_at P30 2.04 28
LPS-responsive beige-like anchor 104264_at P15 1.86 95.3
Max dimerization protein 4 99024_at P15 1.95 194.4
Max dimerization protein 4 99024_at P30 1.70 117.1
Metallothionein 1 93573_at P30 1.78 35.6
Metallothionein 2 101561_at P30 1.95 64.4
Midnolin 104410_at P15 1.95 152.9
Mitogen activated protein kinase 8 104047_at P0 0.56 184.2
Mitogen activated protein kinase 8 104047_at P15 2.00 250.6
(continued)
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To confirm the reliability of microarray data, seven differ-
entially expressed genes from the short list of 95 genes
selected by VARAN and ANOVA were analyzed by qPCR
at P0, P15 or P30 (Table 6). From a total of eight experiments
conducted across three developmental stages, six variations
were confirmed. Differential expression of Glutamine synthase
was found to be different when measured by qPCR compared
with microarray, thus suggesting a lack of specificity of the
microarray probe set.
Principal component analysis
For gene profiling across all conditions, trisomic and euploid at
P0, P15 and P30, we performed PCA. With the 8287 genes
detected on the Affymetrix U74Av2 microarray, the projection
onto the subspace spanned by the two first principal components
clearly grouped the animals according to their stage of develop-
ment, thus demonstrating that the effect of development on gene
expression is more important than the trisomic effect (Fig. 4A).
Table 4. Continued
Gene Probe set Stage Ts/Eu ratio U74Av2 Fisher
Myelin and lymphocyte protein, T-cell
differentiation protein
99089_at P15 1.86 35.1
Myeloid ecotropic viral integration site-related
gene 1
97988_at P15 9.77 32
Neurofilament, medium polypeptide 92346_at P15 2.19 29.1
Nucleolar and coiled-body phosphoprotein 1 95735_at P0 0.23 22.6
Open reading frame 60 94386_at P30 1.78 76.1
Phosphatase and tensin homolog 160614_at P30 0.59 13.4
Prosaposin 97560_at P30 0.55 49.2
Protease, serine, 18 92353_at P30 0.32 4.1
Protein tyrosine phosphatase, receptor type, O 100427_at P15 2.19 77.9
Regulated endocrine-specific protein 18 99442_at P15 2.45 27.7
Ribosomal protein L29 94240_i_at P0 0.06 15
Ribosomal protein, large, P1 161480_i_at P30 1.62 1.9
RIKEN cDNA 1500036F01 gene 160264_s_at P15 2.34 52
RIKEN cDNA 1810007M14 gene 92233_at P30 1.70 58.3
RIKEN cDNA 2610007K22 gene 101962_at P15 1.41 147.7
RIKEN cDNA 2610528C18 gene 160868_at P15 5.01 79
RIKEN cDNA 2810407C02 gene 97292_at P15 1.78 8.4
RIKEN cDNA 2900073H19 gene 103624_at P0 0.22 10.4
RIKEN cDNA 4933406L05 gene 161011_at P15 0.48 8.1
RIKEN cDNA 4933407C03 gene 103748_at P30 0.26 45.7
RIKEN cDNA 5930418K15 gene 102870_at P0 1.95 361.4
RIKEN cDNA 5930418K15 gene 102870_at P15 0.60 217.5
RIKEN cDNA 6330403K07 gene 95559_at P15 2.00 130.5
RIKEN cDNA 9430059D04 gene 99591_i_at P15 0.50 23.7
Short stature homeobox 2 99042_s_at P15 5.50 36.5
Small inducible cytokine subfamily D, 1 98008_at P15 2.29 98.4
Somatostatin 95436_at P15 3.09 21.2
Thymus cell antigen 1, theta 99057_at P15 1.51 47.2
Transthyretin 95350_at P0 0.39 304.2
Tyrosine hydroxylase 100690_at P15 2.75 36.1
Unc4.1 homeo box (Caenorhabditis elegans ) 92499_at P15 0.51 52.6
X-linked lymphocyte-regulated 3b 101883_s_at P30 3.98 116.8
Zeta-chain (TCR) associated protein kinase (70 kDa) 93662_s_at P15 4.68 5.7
Zinc finger protein 179 100383_at P15 0.52 23
Grey indicates genes from the triplicated genomic segment from mouse chromosome 16. Bold indicates genes that were shown to be dysregulated at
two time points.
Table 5. Number of differentially expressed genes among the 8287 at P0, P15 and P30 according to ANOVA (rejection rate of H0, see Materials and Methods)
P0/P15 P15/P30 Ts/Eu at P0 Ts/Eu at P15 Ts/Eu at P30
a fa(1, 6) m ¼ 0 a2 ¼ 0 a3 ¼ 0 b1 ¼ 0 b2 ¼ 0 b3 ¼ 0
1% 13.745 7959 (96.0%) 2038 (24.6%) 2282 (27.5%) 419 (5.1%) 339 (4.1%) 257 (3.1%)
0.1% 35.51 7704 (92.96%) 1136 (12.50%) 1195 (14.42%) 105 (1.27%) 94 (1.13%) 61 (0.74%)
0.01% 82.489 7377 (89.0%) 506 (6.1%) 610 (7.4%) 26 (0.3%) 25 (0.3%) 14 (0.2%)
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PCA was then performed on subsets of genes of increasing size,
the genes being ranked according to their discriminatory power
for trisomy using Student statistic on data from either euploid
mice or trisomic mice whatever their stage of development
(see Materials and Methods). For the first 100 genes, PCA
grouped the animals according to the trisomic versus euploid
state (Fig. 4D). However on larger subsets (3000 genes),
animals were grouped according to their developmental stage
(Fig. 4B). With 3000 genes, within each stage of development,
Ts1Cje animals could be distinguished from the euploids. The
use of 2000 genes resulted in an intermediate situation where
the most likely separation was made according to the trisomic
versus euploid state, although one could also still get a separ-
ation according to the stage of development (Fig. 4C).
Comparison of microarray data from the literature
Our data set was compared to those of two microarray studies
published recently: that of Saran et al. (6) performed on adult
(3–4 months) cerebellum from Ts65Dn mice, another mouse
segmental trisomy 16 with a larger trisomic fragment (App
to Znf295 ), and that of Amano et al. (7) performed on
whole brains from Ts1Cje mice at P0. To compare all three
studies, the data sets were represented the same way,
namely the value of the statistic (t-test) with respect to the
expression ratio of trisomic versus euploid (Fig. 5). For the
study of Saran et al. (6), only the pools were analyzed. For
our study, trisomic and euploid animals were grouped together
whatever their stage of development, and a t-test was applied.
During postnatal development of the cerebellum in Ts1Cje
mice (our study), there were genes differentially expressed
(up and down), some from the triplicated region (seven over
29 detected on microarray) and some from the euploid
region (44 over 8258) (Fig. 5A). In whole brain at P0 in
Ts1Cje mice, most of the differentially expressed genes were
up-regulated, with mainly genes from the triplicated region
(25 over 45 and 76 over 10557 for the triplicated and euploid
genes, respectively) (Fig. 5B). Finally, in the cerebellum of
adult Ts65Dn mice (3–4 months), there were genes up- and
down-regulated, with a large proportion from the triplicated
region (10 over 20 and 337 over 6581 for the triplicated and
euploid genes, respectively) (Fig. 5C). This comparative analy-
sis revealed that the percentage of differentially expressed genes
varies among studies, from 0.61 (our study when pooling the
three time points) to 0.95% in Amano et al. (7), 5.35% in
Saran et al. (6) and 5.1, 4.1 and 3.1% (our study at P0, P15
and P30, respectively, Table 5 and Fig. 3) with a constant
higher proportion of triplicated up-regulated genes when com-
pared with euploid up-regulated genes.
Using the same statistical analysis of microarray data
(VARAN), three genes/ESTs from the euploid genomic region
were found to be differentially expressed in the cerebellum
of both Ts1Cje mice at P30 (our study) and Ts65Dn mice at
3–4 months (6): one repressed (MGI 96021 corresponding
to hemoglobin b1 major chain) and two overexpressed
(Riken cDNA 1810007M14 and probe set Affymetrix 98525
corresponding to C21orf66 and to erythroid differentiation
regulator 1 Erdr1, respectively).
DISCUSSION
Gene-dosage effect of the triplicated genes from mouse
chromosome 16 (MMU16) during postnatal development
of the cerebellum in Ts1Cje mice
Study of the cerebellar transcriptome during postnatal deve-
lopment in the Ts1Cje model of Down syndrome clearly
Table 6. Comparison between Ts1Cje/euploid expression ratios of genes
selected by VARAN (16) obtained either by qPCR or from the Affymetrix
U74Av2 microarray data
Gene Ts/Eu at P0 Ts/Eu at P15
U74Av2 qPCR U74Av2 qPCR
ALDR 0.46 0.44
Astrotactin 0.79 0.23
Dlx1 80 70.8
Glutamine synthase 1.09 0.45 1.1 2.69
Homeo box A5 0.12 0.13
Transthyretin 0.12 0.39
Uncx4.1 0.80 0.51
Figure 3. Statistical analysis of genes from microarray data differentially expressed between Ts1Cje mice and euploid mice at P0 (A), P15 (B) and P30 (C).
Asterisks, crosses and open circles correspond to MMU16 trisomic genes, MMU16 euploid genes and non-MMU16 euploid genes, respectively. ANOVA:
a ¼ 1%, n ¼ 6, N ¼ 12 (see Materials and Methods).
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shows an overexpression of the three copy-genes, with mean
ratios over postnatal development of 1.43 and 1.52 as deter-
mined by microarray and qPCR experiments, respectively.
These results are in agreement with other studies published
recently (6,7,17,19), thus demonstrating that there is a consist-
ent modification in the number of transcripts throughout
development resulting from a gene-dosage effect. From
qPCR, not all genes had a 1.5 expression ratio between
Ts1Cje and euploid, thus suggesting that there might be
subtle compensatory mechanisms to the gene-dosage effect
as discussed previously (17,19). Gene-dosage effects on the
genome and transcriptome have been described in tumors
(20,21), but there are genes for which the level of expression
is not strictly dependent on the gene copy number, again
suggesting the existence of compensatory mechanisms (22).
Development has a greater effect than trisomy on
global gene expression
Global gene expression profiling during postnatal develop-
ment of the cerebellum enables mice to be classified according
to their stage of development rather than to their trisomic
versus eusomic status. This indicates that development has
more impact on the expression profile than does gene-dosage
(Fig. 4A). Furthermore, gene expression profiles of the
Ts1Cje cerebellum at P15 and P30 were not closer to the
euploid animals at P0 and P15, respectively, thus indicating
that there was no developmental delay in Ts1Cje mice
(Fig. 4A). Figure 3 showed that there were more genes
differentially expressed with significant statistical values at
P0 and P15 than at P30. In addition, qPCR on triplicated
genes indicated that there was a highly significant correlation
(P , 0.01) between the P15 and P30 time points, but not
between P0 and P15 or P30, suggesting that the developmental
changes occurred between P0 and P15, and then stabilized.
Gene expression dysregulation of euploid genes
Statistical analysis revealed a group of dysregulated genes
with ratios ranging from 0.1 to 0.8 and from 1.2 to 70.7
(short list in Table 4). The analysis was validated by qPCR
on a group of seven genes, and the differential expression of
six were confirmed. Comparative analysis of microarray data
[our study on Ts1Cje and study of Saran et al. (6) on the cere-
bellum of adult Ts65Dn mice] revealed euploid genes that are
severely differentially expressed (up or down) with large stati-
stical values (Fig. 5A and C). In the transcriptome study on
whole brain from Ts1Cje at P0, most differentially expressed
genes were from the triplicated genomic segment, with ratios
below 2 (7) (Fig. 5B). Because whole brain is a mixture
of many different cell types, including cerebellar cells, cell-
specific regulation is diluted and below the level of detection.
Reducing cellular complexity by the use of cerebellum
increases the chance of seeing genes that are differentially
expressed in a particular cell type. Using even smaller brain
structures may reveal differentially expressed genes that are
specific for one region of the brain. The higher number of
dysregulated genes found in our study (5.1, 4.1 and 3.1%
Figure 4. PCA on 8287 expressed genes from mouse genome U74Av2 Affymetrix microarrays at P0, P15 and P30 (A) and on subsets of genes ranked according
to trisomic versus euploid state using a t-test: the first 3000 genes (B), 2000 genes (C) and 100 genes (D), Open and filled symbols correspond to euploid and
trisomic mice respectively. Circles, triangles and lozenges correspond to P0, P15 and P30 respectively.
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at P0, P15 and P30, respectively, Table 5) and in the study of
Saran et al. (6) in adult Ts65Dn cerebellum (5.35%) as com-
pared to 0.95% in the study of Amano et al. (7) on whole brain
of Ts1Cje at P0 could relate to the complexity of the tissue
used. In a similar way, pooling the same tissue (cerebellum)
at different time points (P0, P15 and P30) decreased the
number of differentially expressed genes to 0.61% (Fig. 5A).
From VARAN analysis, two euploid genes were selected as
differentially expressed both from our study (Ts1Cje at P30)
and from the data of Saran et al. (6) (Ts65Dn at 3–4
months). One, corresponding to hemoglobin b1 chain, was
repressed, and the other, corresponding to erythroid differen-
tiation regulator, was overexpressed. Supplementary Material,
Table S4 shows that several hemoglobin a- and b-subunits
were highly repressed at P30 and P15, thus suggesting a
decrease in the amount of meninges that surround the cerebel-
lum. Additional experiments done on animals bred on the
same genetic background and at the same time points will
be necessary to draw a final conclusion on particular genes.
Pathways modified during postnatal development of
the cerebellum in Ts1Cje mice: cell differentiation
and development
We used gene ontology to categorize the differentially
expressed genes from our microarray experiments and found
that at P0 there was an enrichment of genes involved in
cell differentiation and development. This suggests that cell
differentiation and migration of cells might be more affected
by trisomy than cell proliferation. At P0, of the 17 genes
known to be involved in development, six are homeobox
genes, all of which were repressed. In addition, at P15 and
P30, respectively, 12 and one homeobox genes were found
to be differentially expressed. Homeoproteins are involved
in the early patterning of the nervous system and possibly at
later stages of neuronal differentiation (23). Among them,
Homeo box A5 was found to be severely down-regulated (to
0.12) at P0 in our study, as well as in two pools of cerebellum
from adult Ts65Dn mice (0.47 and 0.54) (6). In the study of
Amano et al. (7) on whole brain of Ts1Cje mice, Homeo
box A5 was not detected. Homeo box A5 is mostly
expressed during the neonatal period, but there are studies
relating to its expression in the adult, particularly in Purkinje
cells, where it activates the transcription of Purkinje cell
protein 2 (24).
At P15, Dlx1 was found to be overexpressed in Ts1Cje
mice when compared with euploid mice (Table 6: 80-fold
and 70.8-fold by microarray and qPCR, respectively). This
very high ratio probably indicates that Dlx1 is expressed only
in trisomic cerebellum. Dlx1 is not known to be involved in
postnatal development of the cerebellum. However, its role in
the lineage of a particular type of GABAergic interneurons
in human neocortex has been demonstrated recently (25).
In addition, an increase of Dlx1 and Dlx2 negatively regulates
the Notch signalling to specify a later subset of neuronal pro-
genitors and promote their terminal differentiation (26). Dlx2
was also found to be increased at P15 (7-fold; Supplementary
Material, Table S4). It is therefore likely that increase of Dlx1
and Dlx2 may be associated with cell differentiation. We
cannot exclude significant changes in the expression of tran-
scription factors important for development of the cerebellum,
such as Math1, Mash1 and Shh, that have been described in
microarray studies (14), as they were not present on the
Affymetrix U74Av2 microarray. More data on these particular
genes will be useful for understanding cerebellum develop-
ment, as Math1 has recently been shown to be involved in
the control of cerebellar granule cell differentiation by regulat-
ing multiple components of the Notch signalling pathway (27).
Study of gene expression of Notch receptors and ligands and
transcription factor targets will confirm whether the Notch
pathway is altered in Down syndrome.
Gene profiling from the study of Diaz et al. (14) on cerebel-
lum mutants (weaver and lurcher ) were compared to gene
profiling in Ts1Cje mice using the same statistical analysis
(ANOVA with the parameterization described in Materials
and Methods). In weaver mice, granule cells are severely
reduced in the internal layer of the adult cerebellum,
whereas in lurcher mice, Purkinje cells are reduced (28,29).
Comparison of Ts1Cje, weaver and lurcher revealed more
similarity between Ts1cje and weaver mutants than between
Ts1Cje and lurcher mutants (unpublished data). This is con-
sistent with morphological data (13) suggesting that granule
cells, rather than Purkinje cells, are altered in Ts1Cje mice.
Figure 5. Comparison of differentially expressed genes in three studies. (A) in Ts1Cje cerebellum at P0, P15 and P30: our study, (B) in whole brain Ts1Cje at P0:
Amano et al. (7) and (C), in Ts65Dn cerebellum at 3–4 months: Saran et al. (6). For comparing the three studies, a t-test was applied to all three sets of data.
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The list of genes differentially expressed also includes
transthyretin, a transporter of thyroid hormone and vitamin
A, which has been shown to be a carrier of amyloid beta
peptide in the cerebrospinal fluid. Transthyretin prevents
formation of amyloid fibrils and Apo-E-induced accumulation
of amyloid beta (30,31). In Ts1Cje mice, transthyretin was
repressed on microarrays and by qPCR at P0 (Table 6).
Repression of transthyretin, if present in Down syndrome,
might contribute to the amyloid beta deposition process in
brain in addition to APP overexpression.
Another gene expression study in Down syndrome has
shown that REST (neuron-specific silencer factor) and its
targets (SCG10, L1, synapsin) are down-regulated in neuronal
precursor cells from Down syndrome fetal cortex (32). From
our study, expression of SCG10, synapsin and L1, but not of
REST, was detected during postnatal development of the
cerebellum. Only L1 was found to be differentially expressed,
with a ratio of 0.52 between Ts1Cje and euploid at P0, although
with low statistical value (Fisher ¼ 4.6 under the 1%
threshold). Our data do not, therefore, provide evidence for or
against the hypothesis of down-regulation of REST pathway
in neuronal precursor cells proposed by Bahn et al. (32).
In conclusion, in the Ts1Cje mouse model of Down syn-
drome, the presence of three copies of 85 genes having
orthologues on human chromosome 21 induces a consistent
change in expression of these triplicated genes throughout
postnatal development. In addition to this general gene-
dosage effect, where the expected 1.5 overexpression ratio is
largely but not totally respected, a number of euploid genes
are differentially expressed in a time-dependant manner,
with an over-representation of transcripts involved in cell
differentiation and development. Finally, gene profiling
reveals that development has more impact on the transcrip-
tome than the trisomic/eusomic status, and that there is no
detectable delay in the postnatal development of the cerebel-
lum of the segmental trisomy Ts1Cje mice.
MATERIALS AND METHODS
Mice
Ts1Cje mice carry a segmental duplication of the MMU16
region from Sod1 to Znf295. Ts1Cje mice were bred on a
C57BL/6 background (11 backcrosses). For gene expression
analysis, three pairs of euploid (C57BL/6) and trisomic
Ts1Cje male sibs from two litters were used for each develop-
mental stage P0, P15 and P30.
Genotyping
Because the trisomic segment of MMU16 has a truncated Sod1
allele with the neomycin resistance cassette, the mice were
first typed on genomic DNA from the tail by PCR using
Neo primers (10).
In addition, after individual RNA extraction (discussed sub-
sequently), all animals were tested for the presence of both
Sod1 wild-type and truncated alleles by PCR on cDNAs using
Sod1 primers: up—CAATGTGACTGCTGGAAAGG and
low—ATCCCAATCACTCCACAGGC. For each mouse,
500 ng of total RNA from cerebellum were reverse-transcribed
overnight at 378C in the presence of 200 U of Superscript II
(InVitrogen), 1 first-strand buffer, 100 mM DTT, 5 mM
random hexamers oligonucleotides (Pasteur Institute) and
500 mM dNTPs. PCRs were performed using 2.5 U of Hot-
startTaqw DNA polymerase (Qiagen) with 1 PCR buffer
containing 1.5 mM MgCl2, 0.3 mM of each primer and
200 mM dNTPs for 40 cycles of 948C for 30 s, 588C for
30 s, 728C for 40 s. Because one of the P30 euploid mice
showed a pattern with an unexpected number of bands, we
decided not to use it, and the euploid P30 pool was therefore
composed of only two animals instead of three.
RNA extraction and microarray hybridizations
Total RNA was extracted from frozen individual cerebellum
and treated with DNase using RNeasy Midi kit (Qiagen).
The quality of each RNA sample was then checked using
the Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.,
Palo Alto, CA, USA).
For the three postnatal stages, euploid and trisomic samples
were prepared by pooling an equal amount of each individual
RNA. An aliquot 20 mg of total RNA from each pool was
converted to cDNA and then to biotinylated cRNA, and
were hybridized to Affymetrix Murine Genome U74A
version 2 microarrays (Affymetrix, Inc., Santa Clara, CA,
USA) on the Curie Institute Affymetrix microarray platform
(Paris, France), according to the Affymetrix procedures.
Each pool was hybridized in duplicate on independent
U74Av2 microarrays.
Data analysis: filtering, normalization, VARAN and
ANOVA and ontology
After hybridization, signal intensities were calculated using
the Affymetrix GeneChipw software MAS 5.0. The software
generates a ‘detection P-value’ and a ‘detection call’ to
decide whether a gene is expressed, and then attributes to
each gene a status: present, absent or marginal. For further
analysis, we used only the 8287 genes that were defined as
‘Present’ or ‘Marginal’ in Ts1Cje or euploid mice at least at
one time point. Genes called ‘Absent’ in all conditions were
not used for further analysis.
We have deposited all the raw data (accession number
GSE1611) in the NCBI public database Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/).
Filtered data (8287 genes) were submitted to VARAN
(http://www.bionet.espci.fr,) for normalization and differential
expression analysis (16). The microarray measurements were
grouped into six pairs of replicates: euploids at P0, P15, and
P30, and Ts1Cje mice at P0, P15, and P30. The expression
levels were corrected in order to constrain the mean ratio of
each pair to be equal to one using a Lowess fit on the M–A
plot of the log-expression levels (16). In the numerical ana-
lysis, the logarithm of the expression levels was used. For
each experiment replicates on euploid mice (i.e. at P0, P15
and P30), a reference M–A plot was established. Assuming
that the variance of the gene expression level was a function
of their mean, and that the expression levels were Gaussian,
the 1% threshold values for the difference as a function of
the mean were estimated.
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For each stage, the M–A plots of the four possible combi-
nations of euploid and Ts1Cje mice were established, thus pro-
viding four analysis at each time point, and the genes whose
difference of expression between euploid and trisomic
exceeded the 1% threshold values were selected. For the
ANOVA, we applied a regression model for gene expression
levels. Table 1 indicates the parameters faig, which model
the effects of development in euploid mice, and fbig, which
model the effects of trisomy at each development stage. The
number n of parameters equals six, and the number N of
microarray measurements equals 12.
Assuming a Gaussian distribution of gene expression
levels with common variance s2, the sum of squared resi-
duals of the model was x2 distributed: SSR/s2! x2(N2 n ).
If trisomy had no effect at a given stage, we assumed the
nullity of the corresponding parameter (null hypothesis H0).
If H0 is true, (SSR02 SSR)(N2 n )/SSR! Fisher(1, N2 n ),
where SSR0 corresponded to the sum of squared residuals of
the associated submodel. Hence the test rejects H0 if the
Fisher statistic (SSR02 SSR) (N2 n )/SSR. fa(1, N2 n ),
where a denoted the chosen significance level and fa(1, N2 n )
denoted the corresponding quantile of the Fisher distribution.
The hypergeometric distribution was used to calculate the
probability of observing individual GO terms as enriched in
sets of differentially expressed genes relative to the reference
set of expressed genes on the Affymetrix U74Av2 microarray.
Principal component analysis
PCA was first performed on the 8287 expressed genes and
then on subsets of genes of increasing size, the genes being
according to their discriminatory power for trisomy. The
discriminatory power of gene i was measured by the
absolute value of its Student statistic ti:
ti ¼ x
i
Ts 2 x
i
Eu
si
pð1=NTsÞ þ ð1=NEuÞ
where NTs ¼ NEu ¼ 6 was the number of measurements on tri-
somic and euploid mice, respectively, whatever their stage of
development, xiTS and xiEu the mean expression of gene i for
the trisomic and euploid mice, respectively, and si the intra-
class variance estimate.
Real-time quantitative PCR
From each euploid and trisomic pool, 250 ng and 6 mg of total
RNA were individually converted into cDNAs overnight at
378C in the presence of 200 U of Superscript II (In vitrogen),
1 first-strand buffer, 100 mM DTT, 5 mM random hexamers
oligonucleotides (Pasteur Institute) and 500 mM dNTPs.
The cDNAs were then diluted 1:5 and 1:14 for the 250 ng
and 6 mg RNA samples, respectively, for qPCR according to
the following protocols: qPCR on the 78 MMU16 genes and
18 control genes mapping to chromosomes other than 16
were performed as Taqman assays in an ABI 7900 Sequence
Detection System (Applied Biosystems). Assay sequences
are available in Lyle et al. (17). Each expression value corres-
ponds to the mean of five replicates.
qPCR on the seven genes outside MMU16 that were
found to be differentially expressed by microarray analysis
(ALDR, Astrotactin, Dlx1, Glutamine synthase, Homeo box
A5, transthyretin, Uncx4.1 ) were performed in a Lightcycler
system (Roche Molecular Biochemicals), in the presence of
0.5 mM of each specific primer (designed by Oligo4 software)
and 1 QuantitectTM SYBRw Green PCR master mix
(Qiagen) containing 2.5 mM MgCl2, HotstartTaq
w Polymer-
ase, dNTP mix and the fluorescent dye SYBR Green I. Each
reaction was performed in triplicate. The list of primers is
given in Supplementary Material, Table S5. For each sample
tested, three control genes (GAPD, tubulin and Ppox ) that
showed no difference between Ts1Cje and euploids were
used to normalize raw data, and the mean relative ratios Ts/
Eu were calculated according to geNorm (33) as described
in Lyle et al. (17).
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